Komori
Disclosure4974TAKARA BIO INC.Materials and Chemicals

Notice Regarding the Delisting of Our Shares

Following approval of the share consolidation, it has been confirmed that Takara Bio's common shares will meet the Tokyo Stock Exchange's delisting criteria and will be delisted on 12 June 2026.

Worth reading
65In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Decision and Details

Extraordinary General Meeting of Shareholders

Delisting of our shares

Decision20 May 2026
Implementation12 June 2026 (scheduled delisting date)
Going forwardThe shares are scheduled to be delisted as of 12 June 2026
Reason

The proposal concerning the share consolidation was approved as originally proposed, causing the shares to meet the delisting criteria set out in the Tokyo Stock Exchange Securities Listing Regulations.

Decision and Details
ItemDetails
Matter CoveredDelisting of our shares
Decision-Making BodyExtraordinary General Meeting of Shareholders
Decision Date20 May 2026
Implementation Date12 June 2026 (scheduled delisting date)
ReasonThe proposal concerning the share consolidation was approved as originally proposed, causing the shares to meet the delisting criteria set out in the Tokyo Stock Exchange Securities Listing Regulations.
Governing RuleThe delisting criteria prescribed in the Securities Listing Regulations of Tokyo Stock Exchange, Inc.
Related previous disclosuresNotice Concerning the Approval Resolution on the Share Consolidation, the Abolition of the Provisions on the Number of Shares Constituting One Unit and Partial Amendments to the Articles of Incorporation, dated 20 May 2026
Future plansThe shares are scheduled to be delisted as of 12 June 2026
Items this document does not state (4)
Period CoveredAmountQuantity / scaleImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

A proposal concerning the share consolidation was approved at the extraordinary general meeting of shareholders held on 20 May 2026, causing the shares to meet the delisting criteria set out in the Tokyo Stock Exchange Securities Listing Regulations.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Delisting of Our Shares | TAKARA BIO INC. (4974) timely disclosure | Komori